Alteco Medical AB (NGM: ALTE)
Sweden
· Delayed Price · Currency is SEK 0.120
-0.022 (-15.49%)
At close: Nov 18, 2024
Alteco Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 3.41 | 6.06 | 8.22 | 8.26 | 7.86 | 5.73 | Upgrade
|
| Revenue Growth (YoY) | -42.08% | -26.23% | -0.46% | 5.06% | 37.11% | -25.82% | Upgrade
|
| Cost of Revenue | 2.06 | 2.39 | 2.72 | 2.36 | 2.32 | 2.69 | Upgrade
|
| Gross Profit | 1.35 | 3.68 | 5.5 | 5.89 | 5.54 | 3.04 | Upgrade
|
| Selling, General & Admin | 7.69 | 8.7 | 10.44 | 8.76 | 9.37 | 10.66 | Upgrade
|
| Research & Development | 1.06 | 1.4 | 1.32 | 1.3 | 2.3 | 0.41 | Upgrade
|
| Other Operating Expenses | -0.54 | -0.54 | -0.51 | -0.33 | - | - | Upgrade
|
| Operating Expenses | 8.21 | 9.56 | 11.26 | 9.73 | 11.66 | 11.07 | Upgrade
|
| Operating Income | -6.86 | -5.88 | -5.75 | -3.84 | -6.12 | -8.03 | Upgrade
|
| Interest Expense | -0.21 | -0.2 | -0.12 | -0 | -0.04 | -0 | Upgrade
|
| Interest & Investment Income | - | - | 0.04 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.07 | -0.07 | - | -0.02 | -0.13 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | - | - | - | 0 | Upgrade
|
| EBT Excluding Unusual Items | -7.14 | -6.16 | -5.83 | -3.86 | -6.29 | -8.05 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.74 | - | Upgrade
|
| Pretax Income | -7.14 | -6.16 | -5.83 | -3.86 | -7.03 | -8.05 | Upgrade
|
| Net Income | -7.14 | -6.16 | -5.83 | -3.86 | -7.03 | -8.05 | Upgrade
|
| Net Income to Common | -7.14 | -6.16 | -5.83 | -3.86 | -7.03 | -8.05 | Upgrade
|
| Shares Outstanding (Basic) | 54 | 57 | 58 | 55 | 59 | 50 | Upgrade
|
| Shares Outstanding (Diluted) | 54 | 57 | 58 | 55 | 59 | 50 | Upgrade
|
| Shares Change (YoY) | -11.99% | -1.96% | 5.75% | -5.83% | 16.43% | 11.99% | Upgrade
|
| EPS (Basic) | -0.13 | -0.11 | -0.10 | -0.07 | -0.12 | -0.16 | Upgrade
|
| EPS (Diluted) | -0.13 | -0.11 | -0.10 | -0.07 | -0.12 | -0.16 | Upgrade
|
| Free Cash Flow | -7.36 | -3.13 | -8.41 | -4.59 | -7.99 | -6.31 | Upgrade
|
| Free Cash Flow Per Share | -0.14 | -0.05 | -0.14 | -0.08 | -0.14 | -0.13 | Upgrade
|
| Gross Margin | 39.50% | 60.62% | 66.96% | 71.36% | 70.52% | 53.00% | Upgrade
|
| Operating Margin | -201.41% | -97.03% | -70.00% | -46.46% | -77.85% | -140.09% | Upgrade
|
| Profit Margin | -209.58% | -101.52% | -70.96% | -46.75% | -89.42% | -140.41% | Upgrade
|
| Free Cash Flow Margin | -215.93% | -51.58% | -102.36% | -55.52% | -101.62% | -109.98% | Upgrade
|
| EBITDA | -6.64 | -5.59 | -5.31 | -3.41 | -5.81 | -7.79 | Upgrade
|
| EBITDA Margin | -194.98% | -92.20% | -64.63% | -41.24% | -73.90% | -135.84% | Upgrade
|
| D&A For EBITDA | 0.22 | 0.29 | 0.44 | 0.43 | 0.31 | 0.24 | Upgrade
|
| EBIT | -6.86 | -5.88 | -5.75 | -3.84 | -6.12 | -8.03 | Upgrade
|
| EBIT Margin | -201.41% | -97.03% | -70.00% | -46.46% | -77.85% | -140.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.